The Food and Drug Administration (FDA) is taking action to ensure certain information in ClinicalTrials.gov is available to the public. On April 28, 2021, the FDA issued its first notice of non-compliance for failing to submit required results information. A Notice of Noncompliance indicates that the FDA has determined the Responsible Party (Principal Investigator) was […]
New from NIH- Reminder of COVID-19-Related Flexibilities for NIH Grants September 24, 2021When the public health emergency was first declared, NIH, working with OMB and HHS, quickly identified a long list of flexibilities to support the research community. The list has evolved since the pandemic began, so we would like to take this opportunity to remind the community of many of the current flexibilities we have in […]Mike Lauer
- Reminder of COVID-19-Related Flexibilities for NIH Grants September 24, 2021
- News from the Office of Technology Transfer